RVMDW vs RUMBW: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

RUMBW has stronger fundamentals based on our AI analysis.

RVMDW
Revolution Medicines, Inc.
STRONG SELL
88%
Confidence
VS
RUMBW
Rumble Inc.
SELL
78%
Confidence

RVMDW vs RUMBW Fundamental Comparison

Metric RVMDW RUMBW
Revenue $0.0 $100.6M
Net Income $-1.1B $-81.8M
Net Margin N/A -81.3%
ROE -69.3% -29.8%
ROA -48.0% -24.3%
Current Ratio 7.14x 5.84x
Debt/Equity 0.00x 0.00x
EPS $-5.95 $-0.32

Green = Better metric | Red = Weaker metric

View Full RVMDW Analysis →
View Full RUMBW Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

RVMDW vs AAPL RUMBW vs MSFT RVMDW vs GOOGL RUMBW vs AMZN

RVMDW vs RUMBW: Frequently Asked Questions

Is RVMDW or RUMBW a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), RUMBW has stronger fundamentals. RVMDW is rated STRONG SELL (88% confidence) while RUMBW is rated SELL (78% confidence). This is not investment advice.

How does RVMDW compare to RUMBW fundamentally?

Revolution Medicines, Inc. has ROE of -69.3% vs Rumble Inc.'s -29.8%. Net margins are N/A vs -81.3% respectively.

Which stock pays higher dividends, RVMDW or RUMBW?

RVMDW has a dividend yield of N/A or no dividend while RUMBW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in RVMDW or RUMBW for long term?

For long-term investing, consider that RVMDW has STRONG SELL rating with 88% confidence, while RUMBW has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about RVMDW vs RUMBW?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RVMDW vs RUMBW, the AI consensus favors RUMBW based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.